Trial site
Merritt Island Medical Research, LLC
- 9running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease13 trials
- Osteoarthritis2 trials
- Frontotemporal dementia1 trial
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Cassava Sciences, Inc.2 trials
- Annovis Bio Inc.1 trial
- Bristol-Myers Squibb1 trial
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
- and 1 more
Running trials
Not yet recruiting
An Open-label Long-term Safety Study of Buntanetap in Participants With AD
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Osteoarthritis2 recruiting
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026